Evaluation of Ocoxin®-Viusid® in Breast Cancer

Clinical trial NCT03576521 · COMPLETED

Trial details

NCT number: NCT03576521
Sponsor: Catalysis SL
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Breast Carcinoma Adriamycin Toxicity Cyclosporine Toxicity

Start date: 2015-05-13
Primary completion: 2018-01-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.